Skip to main navigation Skip to search Skip to main content

Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies

  • Leonard J. Appleman
  • , Jan H. Beumer
  • , Yixing Jiang
  • , Yan Lin
  • , Fei Ding
  • , Shannon Puhalla
  • , Leigh Swartz
  • , Taofeek K. Owonikoko
  • , R. Donald Harvey
  • , Ronald Stoller
  • , Daniel P. Petro
  • , Hussein A. Tawbi
  • , Athanassios Argiris
  • , Sandra Strychor
  • , Marie Pouquet
  • , Brian Kiesel
  • , Alice P. Chen
  • , David Gandara
  • , Chandra Belani
  • , Edward Chu
  • Suresh S. Ramalingam

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science